iTeos Therapeutics Inc.: iTeos to Present at the Jefferies Virtual Healthcare Conference
CAMBRIDGE, Mass. and GOSSELIES, Belgium, May 26, 2021 (GLOBE NEWSWIRE) iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:00 a.m. ET.
A live webcast of the presentation will be available on the Investors section of the company s website at https://www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation.
Surgery Partners, Inc to Present at Upcoming Investor Conference forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
NEW YORK, May 26, 2021 /PRNewswire/ Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that David Hung, M.D., founder and chief executive officer of Nuvation Bio, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 9:00 a.m. ET.
The fireside chat will be webcast live and can be accessed under Events & Presentations in the Investors section of the Company s website at www.nuvationbio.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Heidelberg, Germany, May 26, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its Chief Executive Officer, Dr. Adi Hoess, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be accessible on Affimed’s website at https://www.affimed.com/investors/webcasts cp/. A replay of the call will be archived on Affimed’s website for 30 days after the call. For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at a.fudukidis@affimed.com or phone at +1 (917) 436-8102. About Affimed N.V.Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the u